Type Congenic; Mutant Strain; Targeted Mutation; Additional information on Genetically Engineered and Mutant Mice. Visit our online Nomenclature tutorial. Additional information on Congenic nomenclature. Mating System Heterozygote x Heterozygote (Female x Male) 02-APR-13 Species laboratory mouse Generation N10pN1+ (29-APR-13)
Generation DefinitionsDonating Investigator Kevin R. Jones, University of Colorado- Boulder Description
Brain derived neurotrophic factor is important for survival of neurons, regulates neuronal differentiation and is involved in synaptic plasticity as well as mediation of food intake and body weight. These mice possess loxP sites on either side of exon 5 of the targeted gene, with polyadenylation sequence upstream of the 3' loxP site, and lacZ downstream of the 3' loxP site. Mice that are homozygous for this allele are viable, obese and are poor breeders. The Donating Investigator reports that homozygotes exhibit subtle neurological abnormalities. The phenotype of homozygotes is probably due to disruption by insertion of lacZ and loxP sites into the locus. When these mutant mice are bred to mice that express Cre recombinase, resulting offspring will have exon 5 deleted and express lacZ in the cre-expressing tissues.When bred to mice carrying Tg(Wnt1-cre)11Rth (see Stock No. 009107 for example) Cre recombinase expression in midbrain/neural tube results in exhibit hindlimb clutching, poor rotarod performance, and alterations in the substantia nigra.
Development
A targeting vector designed by Dr. Kevin R. Jones (University of Colorado, Boulder) was used to flank exon 5 with loxP sites and insert a polyadenylation sequence upstream of the 3' loxP site, and lacZ and a FRT site flanked PGK-NEO cassette downstream of the 3' loxP site. This construct was electroporated into 129S2/SvPas derived D3 embryonic stem (ES) cells. Correctly targeted ES cells were injected into blastocysts. The resulting chimeric animals were crossed to C57BL/6 mice. The mice were then crossed to a FLP recombinase expressing strain on an unspecified genetic background (and containing B6 and SJL) to remove the FRT site flanked PGK-NEO cassette. The mice were then backcrossed to C57BL/6 for more than 10 generations. Upon arrival at The Jackson Laboratory, the mice were crossed to C57BL/6J (Stock No. 000664) at least once to establish the colony.
| Control | ||
|---|---|---|
| 000664 C57BL/6J | ||
| Considerations for Choosing Controls | ||
Strains carrying other alleles of Bdnf
002266 B6.129S4-Bdnftm1Jae/J 002267 STOCK Bdnftm1Jae/J 004339 STOCK Bdnftm3Jae/J View Strains carrying other alleles of Bdnf (3 strains)
Use of MICE by companies or for-profit entities requires a license prior to shipping.
Use of MICE by companies or for-profit entities requires a license.
View Related Disease (OMIM) Terms
Related Disease (OMIM) Terms provided by MGI
- Potential model based on gene homology relationships. Phenotypic similarity to the human disease has not been tested. Bulimia Nervosa, Susceptibility to, 1; BULN1 (BDNF)
Central Hypoventilation Syndrome, Congenital; CCHS (BDNF)
Obsessive-Compulsive Disorder; OCD (BDNF)
View Mammalian Phenotype Terms
Mammalian Phenotype Terms provided by MGI
assigned by genotype
The following phenotype information may relate to a genetic background differing from this JAX® Mice strain.
Bdnftm1Krj/Bdnftm1Krj
involves: 129S2/SvPas * C57BL/6
- nervous system phenotype
- *normal* nervous system phenotype
Bdnftm1Krj/Bdnftm1Lfr Tg(Wnt1-cre)11Rth/0
involves: 129S2/SvPas * C57BL/6 * CBA (conditional)
- behavior/neurological phenotype
- impaired coordination
- at 4 - 5 weeks of age performance on the rotarod test is impaired (MGI Ref ID J:99291)
- limb grasping
- at 1 month of age 78% of mutants clutch compared to 8% of wild-type mice and by 6 months all mutants clutch compared to 16% of wild-type (MGI Ref ID J:99291)
- nervous system phenotype
- abnormal substantia nigra morphology
- tyrosine hydroxylase-positive neurons are reduced by about 27% and 23% at postnatal day 0 and 120, respectively and appear disorganized (MGI Ref ID J:99291)
- the extent of the substantia nigra pars compacta appears reduced in coronal sections but the density of calbindin-positive neurons appears increased (MGI Ref ID J:99291)
The following phenotype relates to a compound genotype created using this strain.
Contact JAX® Services jaxservices@jax.org for customized breeding options.Bdnftm1Krj/Bdnf+ Emx1tm1(cre)Krj/Emx1+
involves: 129S2/SvPas * C57BL/6J (conditional)
- growth/size phenotype
- *normal* growth/size phenotype
- forebrain specific heterozygotes do not become obese unlike mice heterozygous for Bdnftm1Lfr (MGI Ref ID J:84683)
View Research Applications
Research Applications
This mouse can be used to support research in many areas including:
Neurobiology Research
lacZ expression in neural tissue
Cre-lox System
loxP-flanked Sequences
Research Tools
lacZ Expression
Cre-lox System
loxP-flanked Sequences: Test/Reporter
Diabetes and Obesity Research
lacZ
| Allele Symbol | Bdnftm1Krj | ||
|---|---|---|---|
| Allele Name | targeted mutation 1, Kevin R Jones | ||
| Allele Type | Targeted (Floxed/Frt) | ||
| Common Name(s) | BDNFlox; Bdnfklox; | ||
| Strain of Origin | 129S2/SvPas | ||
| Gene Symbol and Name | Bdnf, brain derived neurotrophic factor | ||
| Chromosome | 2 | ||
| Gene Common Name(s) | ANON2; BULN2; | ||
| Molecular Note | A targeting construct was designed to flank the pro encoding region and mature hormone-encoding region of exon V with loxP sites, with a trimerized polyadenylation signal just upstream of the 3' loxP sequence and a lacZ gene just downstream of the 3' loxP sequence. Cre mediated excision would enable transcription and translation of lacZ in place of Bdnf. [MGI Ref ID J:84683] | ||
Genotyping Protocols
Bdnftm1Krj, Standard PCR
Helpful Links
Genotyping resources and troubleshooting
Gorski JA; Zeiler SR; Tamowski S; Jones KR. 2003. Brain-derived neurotrophic factor is required for the maintenance of cortical dendrites. J Neurosci 23(17):6856-65. [PubMed: 12890780] [MGI Ref ID J:84683]
Bdnftm1Krj relatedAn JJ; Gharami K; Liao GY; Woo NH; Lau AG; Vanevski F; Torre ER; Jones KR; Feng Y; Lu B; Xu B. 2008. Distinct role of long 3' UTR BDNF mRNA in spine morphology and synaptic plasticity in hippocampal neurons. Cell 134(1):175-87. [PubMed: 18614020] [MGI Ref ID J:138312]
Baquet ZC; Bickford PC; Jones KR. 2005. Brain-derived neurotrophic factor is required for the establishment of the proper number of dopaminergic neurons in the substantia nigra pars compacta. J Neurosci 25(26):6251-9. [PubMed: 15987955] [MGI Ref ID J:99291]
Baquet ZC; Gorski JA; Jones KR. 2004. Early striatal dendrite deficits followed by neuron loss with advanced age in the absence of anterograde cortical brain-derived neurotrophic factor. J Neurosci 24(17):4250-8. [PubMed: 15115821] [MGI Ref ID J:96903]
Baydyuk M; Russell T; Liao GY; Zang K; An JJ; Reichardt LF; Xu B. 2011. TrkB receptor controls striatal formation by regulating the number of newborn striatal neurons. Proc Natl Acad Sci U S A 108(4):1669-74. [PubMed: 21205893] [MGI Ref ID J:168326]
Baydyuk M; Xie Y; Tessarollo L; Xu B. 2013. Midbrain-derived neurotrophins support survival of immature striatal projection neurons. J Neurosci 33(8):3363-9. [PubMed: 23426664] [MGI Ref ID J:194255]
English CN; Vigers AJ; Jones KR. 2012. Genetic evidence that brain-derived neurotrophic factor mediates competitive interactions between individual cortical neurons. Proc Natl Acad Sci U S A 109(47):19456-61. [PubMed: 23129644] [MGI Ref ID J:192261]
Fox EA; Biddinger JE; Jones KR; McAdams J; Worman A. 2013. Mechanism of hyperphagia contributing to obesity in brain-derived neurotrophic factor knockout mice. Neuroscience 229:176-99. [PubMed: 23069761] [MGI Ref ID J:193539]
Gorski JA; Balogh SA; Wehner JM; Jones KR. 2003. Learning deficits in forebrain-restricted brain-derived neurotrophic factor mutant mice. Neuroscience 121(2):341-54. [PubMed: 14521993] [MGI Ref ID J:100000]
Kaneko M; Xie Y; An JJ; Stryker MP; Xu B. 2012. Dendritic BDNF synthesis is required for late-phase spine maturation and recovery of cortical responses following sensory deprivation. J Neurosci 32(14):4790-802. [PubMed: 22492034] [MGI Ref ID J:184139]
Rocha-Sanchez SM; Morris KA; Kachar B; Nichols D; Fritzsch B; Beisel KW. 2007. Developmental expression of Kcnq4 in vestibular neurons and neurosensory epithelia. Brain Res 1139:117-25. [PubMed: 17292869] [MGI Ref ID J:118633]
Strand AD; Baquet ZC; Aragaki AK; Holmans P; Yang L; Cleren C; Beal MF; Jones L; Kooperberg C; Olson JM; Jones KR. 2007. Expression profiling of Huntington's disease models suggests that brain-derived neurotrophic factor depletion plays a major role in striatal degeneration. J Neurosci 27(43):11758-68. [PubMed: 17959817] [MGI Ref ID J:127037]
Vigers AJ; Amin DS; Talley-Farnham T; Gorski JA; Xu B; Jones KR. 2012. Sustained expression of brain-derived neurotrophic factor is required for maintenance of dendritic spines and normal behavior. Neuroscience 212:1-18. [PubMed: 22542678] [MGI Ref ID J:184800]
Waterhouse EG; An JJ; Orefice LL; Baydyuk M; Liao GY; Zheng K; Lu B; Xu B. 2012. BDNF promotes differentiation and maturation of adult-born neurons through GABAergic transmission. J Neurosci 32(41):14318-30. [PubMed: 23055503] [MGI Ref ID J:190905]
Animal Health Reports
Room Number FGB29
Colony Maintenance
Breeding & Husbandry When maintaining a live colony, these mice can be bred as heterozygotes. Homozygotes are viable, but are obese and breed poorly. Mating System Heterozygote x Heterozygote (Female x Male) 02-APR-13 Diet Information LabDiet® 5K52/5K67
This strain is currently Under Development - Now Accepting Orders.
Estimated Available for Distribution Date:
17-JUN-13
Please note: You may now place orders for this strain although it is not yet ready for distribution. Estimated available for distribution dates are provided to keep customers better informed on strains under development. Please note that our Colony Managers routinely monitor the target date and edit it based on breeding performance and other factors. The length of time it takes to make a new strain available for distribution depends on genotype, age, number of animals sent by the Donating Investigator, breeding performance, additional strain development (backcrossing, making homozygous), and anticipated demand for the strain.
| Pricing for USA, Canada and Mexico shipping destinations |
|
Price per mouse (US dollars $) Gender Genotypes Provided Individual Mouse $232.00 Female or Male Heterozygous for Bdnftm1Krj $232.00 Female or Male Homozygous for Bdnftm1Krj
Price per Pair (US dollars $) Pair Genotype $464.00 Heterozygous for Bdnftm1Krj x Heterozygous for Bdnftm1Krj Standard Supply
Under Development - Now Accepting Orders The strain development process (i.e. importation, rederivation, and colony expansion) usually takes six to nine months.
| Pricing for International shipping destinations |
|
Price per mouse (US dollars $) Gender Genotypes Provided Individual Mouse $301.60 Female or Male Heterozygous for Bdnftm1Krj $301.60 Female or Male Homozygous for Bdnftm1Krj
Price per Pair (US dollars $) Pair Genotype $603.20 Heterozygous for Bdnftm1Krj x Heterozygous for Bdnftm1Krj Standard Supply
Under Development - Now Accepting Orders The strain development process (i.e. importation, rederivation, and colony expansion) usually takes six to nine months.
|
|
Under Development - Now Accepting Orders The strain development process (i.e. importation, rederivation, and colony expansion) usually takes six to nine months.
| Control | ||
|---|---|---|
| 000664 C57BL/6J | ||
| Considerations for Choosing Controls | ||
| Control Pricing Information for Genetically Engineered Mutant Strains. | ||
| phone: | 207-288-6470 |
| fax: | 207-288-6655 |
MICE, PRODUCTS AND SERVICES ARE PROVIDED “AS IS”. JACKSON EXTENDS NO WARRANTIES OF ANY KIND, EITHER EXPRESS, IMPLIED, OR STATUTORY, WITH RESPECT TO MICE, PRODUCTS OR SERVICES, INCLUDING ANY IMPLIED WARRANTY OF MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE, OR ANY WARRANTY OF NON-INFRINGEMENT OF ANY PATENT, TRADEMARK, OR OTHER INTELLECTUAL PROPERTY RIGHTS.
In case of dissatisfaction for a valid reason and claimed in writing by a purchaser within ninety (90) days of receipt of mice, products or services, JACKSON will, at its option, provide credit or replacement for the mice or product received or the services provided.
In no event shall JACKSON, its trustees, directors, officers, employees, and affiliates be liable for any causes of action or damages, including any direct, indirect, special, or consequential damages, arising out of the provision of MICE, PRODUCTS or services, including economic damage or injury to property and lost profits, and including any damage arising from acts or negligence on the part of JACKSON, its agents or employees. Unless prohibited by law, in purchasing or receiving MICE, PRODUCTS or services from JACKSON, purchaser or recipient, or any party claiming by or through them, expressly releases and discharges JACKSON from all such causes of action or damages, and further agrees to defend and indemnify JACKSON from any costs or damages arising out of any third party claims.
MICE and PRODUCTS are to be used in a safe manner and in accordance with all applicable governmental rules and regulations.
The foregoing represents the General Terms and Conditions applicable to JACKSON’s MICE, PRODUCTS or services. In addition, special terms and conditions of sale of certain MICE, PRODUCTS or services may be set forth separately in JACKSON web pages, catalogs, price lists, contracts, and/or other documents, and these special terms and conditions shall also govern the sale of these MICE, PRODUCTS and services by JACKSON, and by its licensees and distributors.
Acceptance of delivery of MICE, PRODUCTS or services shall be deemed agreement to these terms and conditions. No purchase order or other document transmitted by purchaser or recipient that may modify the terms and conditions hereof, shall be in any way binding on JACKSON, and instead the terms and conditions set forth herein, including any special terms and conditions set forth separately, shall govern the sale of MICE, PRODUCTS or services by JACKSON.